i just think phylogica need to take potential drugs to an early clinical stage before seeking license deals, rather than just animal data
they could charge higher upfront fees to cover costs and potential partners would feel more confident knowing say clinical phase I trials have been complete and provide some proof of concept
i just can't see the current business model working. imo their money is with their intellectual property and their best hope is to sell it to someone bigger
i would wait for another bottom before buying again
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.42 |
Change
0.030(2.16%) |
Mkt cap ! $828.2M | |||
| Open | High | Low | Value | Volume |
| $1.39 | $1.42 | $1.35 | $262.9K | 189.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7220 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.42 | 31411 | 3 |
View Market Depth
| Last trade - 16.10pm 22/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |